-
Product Insights
NewPostoperative Ileus – Drugs In Development, 2024
Empower your strategies with our Postoperative Ileus – Drugs In Development, 2024 report and make more profitable business decisions. Postoperative ileus is a prolonged absence of bowel function after surgical procedures, usually abdominal surgery. It is caused by interruption of the GI tract, bowel manipulation, anesthetics and analgesics, immobility, electrolyte imbalances, intra-abdominal hematoma, severe infections or sepsis, and chronic medical conditions like diabetes. Symptoms of ileus include bloating, vomiting, constipation, cramps, and loss of appetite. Some drugs used to treat postoperative...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QBS-10072S in Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. QBS-10072S in Lung Cancer Drug Details: QBS-10072S is under development for the treatment of solid...
-
Product Insights
NewNet Present Value Model: Palisade Bio, Inc’s Tranexamic acid
Empower your strategies with our Net Present Value Model: Palisade Bio, Inc's Tranexamic acid report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tranexamic acid in Postoperative Ileus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tranexamic acid in Postoperative Ileus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tranexamic acid in Postoperative IleusDrug Details:Tranexamic acid (LB-1148) is under development for...
-
Company Profile
Palisade Bio, Inc – Company Profile
Palisade Bio, Inc (Palisade Bio), formerly Seneca Biopharma Inc, is a biopharmaceutical company developing novel treatments for nervous system diseases. The company's product pipeline include GT-2108, a microbiota-activated PDE4 inhibitor to treat moderate-to-severe ulcerative colitis; and GT-1908 for treatment of fibro stenotic Crohn’s Disease. It works in collaboration with Giiant Pharma Inc for multiple oral drug candidates targeting inflammatory bowel disease. Palisade Bio is headquartered in Carlsbad, California, the US.
Add to Basket -
Product Insights
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Zika Virus Infections Pipeline Drugs Market Report Overview Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. Risk factors include being in tropical and subtropical areas. Zika virus can be transmitted through sexual intercourse. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The Zika Virus Infections pipeline drugs market research report provides comprehensive information on the Zika...
-
Product Insights
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Glioblastoma Multiforme Pipeline Drugs Market Glioblastoma also known as glioblastoma multiforme is a fast-growing glioma that develops from star-shaped glial cells that support the health of the nerve cells within the brain. Symptoms include headaches, blurred vision, nausea, vomiting, memory loss, speech difficulty, muscle weakness, and loss of appetite. Risk factors include gender (male) and age. Treatment includes surgery, radiation therapy, and chemotherapy. The Glioblastoma Multiforme (GBM) drugs in development market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Drugs Market Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation therapy....
-
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Sclerosis Pipeline Drugs Development Market Report Overview Multiple sclerosis (MS) is a potentially debilitating disease in which the body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes interference in the communication between the brain, spinal cord, and other areas of the body. Symptoms include numbness or weakness in one or more limbs, double vision or blurring of vision, tingling or pain in parts of the body, fatigue, and slurred speech. The...